Johnson & Johnson on Tuesday reported better-than-expected first-quarter results and lifted its sales forecast for the full year.

Johnson & Johnson’s Q1 2025 earnings reveal growth in sales and EPS, boosted by MedTech and Pharma. Click for my updated look at JNJ and its most recent news.

Discover insights from Johnson & Johnson's Q1 2025 earnings call, highlighting 4.2% sales growth, MedTech innovation, and strategies to offset ...

The company's cancer cell therapy Carvykti, which it makes in partnership with Legend Biotech, brought in sales of $369 million, above estimates of $324 million. Quarterly sales of J&J's cancer drugs ...

U.S. to Freeze $2.2 Billion for Harvard After It Defies Trump A Showdown Between the White House and the Nation’s Wealthiest University The move came after the school said it would not submit to ...